More Globe Newswire

View Older Stories View Newer Stories

Apr 30, 2024 07:00AM Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
Apr 30, 2024 07:00AM Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
Apr 30, 2024 07:00AM Atico Updates Mineral Reserves and Resources for the El Roble Mine in Colombia
Apr 30, 2024 07:00AM Capital Product Partners L.P. Announces First Quarter 2024 Financial Results
Apr 30, 2024 07:00AM ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
Apr 30, 2024 07:00AM Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Apr 30, 2024 07:00AM OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARV
Apr 30, 2024 07:00AM PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
Apr 30, 2024 07:00AM Luckin Coffee Inc. Announces First Quarter 2024 Financial Results
Apr 30, 2024 07:00AM Chinese Steel Producer Orders World’s Most Powerful Continuous Caster from Primetals Technologies
Apr 30, 2024 07:00AM Aduro Clean Technologies Reports Third Quarter 2024 Financial Results
Apr 30, 2024 07:00AM Oatly Reports First Quarter 2024 Financial Results
Apr 30, 2024 07:00AM HALLADOR ENERGY COMPANY TO ANNOUNCE FIRST QUARTER 2024 RESULTS
Apr 30, 2024 07:00AM Playboy Enters into Multiple New China License Agreements
Apr 30, 2024 07:00AM LGI Homes Reports First Quarter 2024 Results
Apr 30, 2024 07:00AM ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
Apr 30, 2024 07:00AM Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
Apr 30, 2024 07:00AM Galaxy Market - Making Foundation Introduces GLT Coin, Catalyzing a New Phase in Pledge Mining and Digital Governance
Apr 30, 2024 07:00AM Plug to Announce 2024 First Quarter Results
Apr 30, 2024 07:00AM Climb Channel Solutions' Commitment to Excellence Recognized with Multiple Prestigious Awards in Q1 2024
Apr 30, 2024 07:00AM ATHA Energy Completes Angilak Project Equipment and Supply Mobilization, Update on Commencement of Diamond Drilling
Apr 30, 2024 07:00AM Solaris Announces Award of Option to Acquire Key Concessions Hosting Porphyry Copper and Epithermal Gold Potential Adjacent to Warintza
Apr 30, 2024 07:00AM CW Petroleum Corp (CWPE) Reports Fiscal Year Ended 2023, Profitability
Apr 30, 2024 07:00AM Enthusiast Gaming’s U.GG Expands Insights Platform into Riot’s Teamfight Tactics
Apr 30, 2024 07:00AM CECO Environmental Reports First Quarter 2024 Results
Apr 30, 2024 07:00AM PyroGenesis Kicks Off New European Distribution Strategy with Contract to Supply Spanish Aerospace Entity with Titanium Metal Powder
Apr 30, 2024 07:00AM OTC Markets Group Welcomes Osprey Solana Trust to OTCQX
Apr 30, 2024 07:00AM Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
Apr 30, 2024 07:00AM Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
Apr 30, 2024 07:00AM AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call
Apr 30, 2024 07:00AM ZeroFox Threat Intelligence and Attack Surface Experts to Present at 2024 RSA Conference
Apr 30, 2024 07:00AM The recording of Šiaulių Bankas Investor Conference Webinar of introducing the financial results for Q1 2024
Apr 30, 2024 07:00AM CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development
Apr 30, 2024 07:00AM ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
Apr 30, 2024 07:00AM Replay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies
Apr 30, 2024 07:00AM Change in number of shares and votes in HMS Networks
Apr 30, 2024 06:58AM Invitation to FLSmidth “Meet the Management” Investor Event, 22 to 23 September 2024
Apr 30, 2024 06:55AM Martin Marietta Reports First-Quarter 2024 Results
Apr 30, 2024 06:54AM Defiance ETFs Announces Monthly Distributions on $QQQY (66.36%), $JEPY (54.28%), $IWMY (102.97%), $TRES (11.70%), and $SPYT (19.79%)
Apr 30, 2024 06:51AM Notice of Virtual Annual General Meeting of Coinshares International Limited on 31 May 2024
Apr 30, 2024 06:46AM Correction to company announcement no. 25 of 30 April 2024
Apr 30, 2024 06:45AM Stantec selected by BC Hydro to provide Transmission & Distribution Engineering and Project Delivery Services
Apr 30, 2024 06:45AM Waldencast Reports Fiscal Year 2023 Financial Results
Apr 30, 2024 06:45AM Stantec selected by BC Hydro to provide Transmission & Distribution Engineering and Project Delivery Services
Apr 30, 2024 06:45AM Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
Apr 30, 2024 06:44AM Block Listing Six Monthly Return
Apr 30, 2024 06:30AM Kraken Robotics Receives $8 Million Contract for Sub-Seabed Imaging Services
Apr 30, 2024 06:30AM VAALCO Energy, Inc. Announces Closing of Accretive All Cash Svenska Acquisition
Apr 30, 2024 06:30AM Ransomware Payments Increase 500% In the Last Year, Finds Sophos State of Ransomware Report
Apr 30, 2024 06:30AM eGain to Announce Fiscal 2024 Third Quarter Financial Results on May 9, 2024
View Newer Stories View Older Stories